| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000036754 |
| Receipt No. | R000041883 |
| Scientific Title | The relationship between vascular function and health checkup data in local residents |
| Date of disclosure of the study information | 2019/05/16 |
| Last modified on | 2019/05/15 (Ver. 1) |
| Basic information | ||
| Public title | The relationship between vascular function and health checkup data in local residents | |
| Acronym | The relationship between vascular function and health checkup data in local residents | |
| Scientific Title | The relationship between vascular function and health checkup data in local residents | |
| Scientific Title:Acronym | The relationship between vascular function and health checkup data in local residents | |
| Region |
|
|
| Condition | ||
| Condition | Vascular dysfunction
Frailty |
|
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | The primary objective is to evaluate the relationship of vascular dysfunction with flailty onset using health examination data. |
| Basic objectives2 | Others |
| Basic objectives -Others | Factors for predicting vascular dysfunction and flailty onset |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Incidence of flailty |
| Key secondary outcomes | 1) Development of renal dysfunction
2) Incident of metabolic syndrome |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | The subjects who have two days medical health checkup at Gunma chuo hospital | |||
| Key exclusion criteria | The subjects who do not agree to participate in this study | |||
| Target sample size | 1000 | |||
| Research contact person | |||||||
| Last name of lead principal investigator |
|
||||||
| Organization | Gunma University Hospital | ||||||
| Division name | Clinical Investigation and Research Unit | ||||||
| Zip code | 3710034 | ||||||
| Address | 3-39-15 Showa-machi, Maebashi, Gunma, Japan | ||||||
| TEL | 0272208740 | ||||||
| yoshiaki-ohyama@gunma-u.ac.jp | |||||||
| Public contact | |||||||
| 1st name of contact person |
|
||||||
| Organization | Japan Community Health care Organization Gunma Chuo Hospital | ||||||
| Division name | Department of Pharmacy | ||||||
| Zip code | 3710025 | ||||||
| Address | 1-7-13 Kouncho, Maebashi, Gunma, Japan | ||||||
| TEL | 0272218165 | ||||||
| Homepage URL | |||||||
| araki-mie@gunma.jcho.go.jp | |||||||
| Sponsor | |
| Institute | Japan Community Health care Organization Gunma Chuo Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Japan Society For Promotion Of Science |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | Takasaki University of Health and Welfare |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Japan Community Health care Organization Gunma Chuo Hospita |
| Address | 1-7-13 Kouncho, Maebashi, Gunma, Japan |
| Tel | 0272218165 |
| chiken@gunma.jcho.go.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | Observational study consisting of cross-sectional study followed by longitudinal study.
In addition to the usual health checkup data, the next check is performed. CAVI (Cardio Ankle Vascular Index), ABI (Ankle Brachial Pressure Index), urinary sodium concentration, urinary creatinine, central blood pressure, 24-hour blood pressure, medication survey, activity survey, preference survey, flail index test |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000041883 |